Literature DB >> 26619325

Identification of fungal pathogens in a patient with acute myelogenic leukemia using a pathogen detection array technology.

Sagarika Banerjee1, Kristen N Peck1, Michael D Feldman2, Mindy G Schuster3, James C Alwine4, Erle S Robertson1.   

Abstract

Invasive zygomycosis in immunocompromised patients results in a high mortality rate, and early identification is crucial to optimize therapy and to reduce morbidity. However, diagnosing specific species of zygomycetes fungi possess challenge in the clinical laboratories. A need for a rapid and sensitive diagnostic tool for early recognition of a zygomycetes fungus in clinical samples to the species level will lead to prompt and accurate therapy and the PathoChip provides one such platform. We utilized a pathogen array technology referred to as PathoChip, comprised of oligonucleotide probes that can detect all the sequenced viruses as well as known pathogenic bacteria, fungi and parasites and family-specific conserved probes, thus providing a means for detecting previously uncharacterized members of a family. We rapidly identified a zygomycetous fungus, Rhizomucor pusillus, an otherwise challenge for the clinical laboratories, predominantly in a patient with acute myelogenous leukemia. This report highlights the value of PathoChip as a diagnostic tool to identify micro-organisms to the species level, especially for those difficult to identify in most clinical laboratories. It will also help clinicians to obtain a critical snapshot of the infection profile of a patient to plan treatment strategies.

Entities:  

Keywords:  Acute myelogenous leukemia; PathoChip; Rhizomucor; diagnostic; opportunistic fungal infection; pan-pathogen array; zygomycete

Mesh:

Year:  2016        PMID: 26619325      PMCID: PMC4910928          DOI: 10.1080/15384047.2015.1121349

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  33 in total

1.  A stain for fungi in tissue sections and smears using Gomori's methenamine-silver nitrate technic.

Authors:  R G GROCOTT
Journal:  Am J Clin Pathol       Date:  1955-08       Impact factor: 2.493

Review 2.  DNA and the classical way: identification of medically important molds in the 21st century.

Authors:  S Arunmozhi Balajee; Lynne Sigler; Mary E Brandt
Journal:  Med Mycol       Date:  2007-09       Impact factor: 4.076

Review 3.  Zygomycosis: the re-emerging fungal infection.

Authors:  M Chayakulkeeree; M A Ghannoum; J R Perfect
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 3.267

4.  Phylogeny and PCR identification of clinically important Zygomycetes based on nuclear ribosomal-DNA sequence data.

Authors:  K Voigt; E Cigelnik; K O'donnell
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

5.  Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.

Authors:  Wolfgang A Bethge; Marc Schmalzing; Gernot Stuhler; Ulrike Schumacher; Stefan-Martin Kröber; Marius Horger; Hermann Einsele; Lothar Kanz; Holger Hebart
Journal:  Haematologica       Date:  2005-11       Impact factor: 9.941

6.  DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients.

Authors:  Birgit Spiess; Wolfgang Seifarth; Margit Hummel; Oliver Frank; Alice Fabarius; Chun Zheng; Handan Mörz; Rüdiger Hehlmann; Dieter Buchheidt
Journal:  J Clin Microbiol       Date:  2007-08-22       Impact factor: 5.948

7.  Spectrum of zygomycete species identified in clinically significant specimens in the United States.

Authors:  E Alvarez; D A Sutton; J Cano; A W Fothergill; A Stchigel; M G Rinaldi; J Guarro
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

8.  Nosocomial infection by Rhizomucor pusillus in a clinical haematology unit.

Authors:  A del Palacio Hernanz; J Fereres; S Larregla Garraus; A Rodriguez-Noriega; F Sanz Sanz
Journal:  J Hosp Infect       Date:  1983-03       Impact factor: 3.926

Review 9.  Zygomycosis.

Authors:  Corina E Gonzalez; Michael G Rinaldi; Alan M Sugar
Journal:  Infect Dis Clin North Am       Date:  2002-12       Impact factor: 5.982

10.  Genetic identification of the main opportunistic Mucorales by PCR-restriction fragment length polymorphism.

Authors:  M Machouart; J Larché; K Burton; J Collomb; P Maurer; A Cintrat; M F Biava; S Greciano; A F A Kuijpers; N Contet-Audonneau; G S de Hoog; A Gérard; B Fortier
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

View more
  5 in total

1.  The ovarian cancer oncobiome.

Authors:  Sagarika Banerjee; Tian Tian; Zhi Wei; Natalie Shih; Michael D Feldman; James C Alwine; George Coukos; Erle S Robertson
Journal:  Oncotarget       Date:  2017-05-30

2.  Detection of Microbial Agents in Oropharyngeal and Nasopharyngeal Samples of SARS-CoV-2 Patients.

Authors:  Tyler Seckar; Xiang Lin; Dipayan Bose; Zhi Wei; Joseph Rohrbaugh; Ronald G Collman; Erle S Robertson
Journal:  Front Microbiol       Date:  2021-03-09       Impact factor: 5.640

3.  Prognostic correlations with the microbiome of breast cancer subtypes.

Authors:  Sagarika Banerjee; Zhi Wei; Tian Tian; Dipayan Bose; Natalie N C Shih; Michael D Feldman; Thaer Khoury; Angela De Michele; Erle S Robertson
Journal:  Cell Death Dis       Date:  2021-09-04       Impact factor: 8.469

4.  Distinct Microbial Signatures Associated With Different Breast Cancer Types.

Authors:  Sagarika Banerjee; Tian Tian; Zhi Wei; Natalie Shih; Michael D Feldman; Kristen N Peck; Angela M DeMichele; James C Alwine; Erle S Robertson
Journal:  Front Microbiol       Date:  2018-05-15       Impact factor: 5.640

5.  Vascular endothelial growth factor encoded by Parapoxviruses can regulate metabolism and survival of triple negative breast cancer cells.

Authors:  Dipayan Bose; Sagarika Banerjee; Rajnish Kumar Singh; Lyn M Wise; Erle S Robertson
Journal:  Cell Death Dis       Date:  2020-11-20       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.